Monk BJ - Search Results

1

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study.

You B, Purdy C, Copeland LJ, Swisher EM, Bookman MA, Fleming G, Coleman R, Randall LM, Tewari KS, Monk BJ, Mannel RS, Walker JL, Cappuccini F, Cohn D, Muzaffar M, Mutch D, Wahner-Hendrickson A, Martin L, Colomban O, Burger RA. You B, et al. Among authors: monk bj. J Clin Oncol. 2022 Dec 1;40(34):3965-3974. doi: 10.1200/JCO.22.01207. Epub 2022 Oct 17. J Clin Oncol. 2022. PMID: 36252167 Free PMC article. Clinical Trial.

2

Single-visit program for cervical cancer prevention in a high-risk population.

Burger RA, Monk BJ, Van Nostrand KM, Greep N, Anton-Culver H, Manetta A. Burger RA, et al. Among authors: monk bj. Obstet Gynecol. 1995 Oct;86(4 Pt 1):491-8. doi: 10.1016/0029-7844(95)00204-5. Obstet Gynecol. 1995. PMID: 7675367

3

Prognostic significance of human papillomavirus DNA in vulvar carcinoma.

Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP. Monk BJ, et al. Obstet Gynecol. 1995 May;85(5 Pt 1):709-15. doi: 10.1016/0029-7844(95)00045-s. Obstet Gynecol. 1995. PMID: 7724101 Review.

4

Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy?

Monk BJ, Tewari K, Gamboa-Vujicic G, Burger RA, Manetta A, Berman ML. Monk BJ, et al. Obstet Gynecol. 1995 Mar;85(3):343-8. doi: 10.1016/0029-7844(94)00398-W. Obstet Gynecol. 1995. PMID: 7862369 Clinical Trial.

5

Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.

Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML. Monk BJ, et al. Gynecol Oncol. 1994 Jul;54(1):4-9. doi: 10.1006/gyno.1994.1157. Gynecol Oncol. 1994. PMID: 8020837

6

Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery.

Monk BJ, Walker JL, Tewari K, Ramsinghani NS, Nisar Syed AM, DiSaia PJ. Monk BJ, et al. Gynecol Oncol. 1994 Feb;52(2):222-8. doi: 10.1006/gyno.1994.1035. Gynecol Oncol. 1994. PMID: 8314143

7

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Burger RA, et al. Among authors: monk bj. J Natl Cancer Inst. 1996 Oct 2;88(19):1361-8. doi: 10.1093/jnci/88.19.1361. J Natl Cancer Inst. 1996. PMID: 8827013 Review.

8

A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer.

Monk BJ, Tewari K, Burger RA, Johnson MT, Montz FJ, Berman ML. Monk BJ, et al. Gynecol Oncol. 1997 Dec;67(3):241-7. doi: 10.1006/gyno.1997.4877. Gynecol Oncol. 1997. PMID: 9441770

9

Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging.

Kim PY, Monk BJ, Chabra S, Burger RA, Vasilev SA, Manetta A, DiSaia PJ, Berman ML. Kim PY, et al. Among authors: monk bj. Gynecol Oncol. 1998 Jun;69(3):243-7. doi: 10.1006/gyno.1998.5012. Gynecol Oncol. 1998. PMID: 9648595

10

Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer.

Burger RA, DiSaia PJ, Roberts JA, O'rourke M, Gershenson DM, Homesley HD, Lichtman SM, Barnes W, Moore DH, Monk BJ. Burger RA, et al. Among authors: monk bj. Gynecol Oncol. 1999 Feb;72(2):148-53. doi: 10.1006/gyno.1998.5243. Gynecol Oncol. 1999. PMID: 10021293 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page